US 8,962,321 B2Granted

Mesenchymal stromal cells and uses related thereto

AssigneeOcata Therapeutics, Inc.

InventorsErin Anne Kimbrel, Robert Lanza, Jianlin Chu, Nicholas Arthur Kouris

Life of this patent

Estimating the term…

Abstract

The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.

Claims22

Dependent claims

A method for generating mesenchymal stromal cells comprising culturing hemangioblasts under conditions that give rise to mesenchymal stromal cells.

Dependencies are inferred from the claim text.

Facts

Application: 13/691,349Filed 30 Nov 2012 · us provisional application
Priority: 30 Nov 2011
Published: US 2013/0183272 A118 Jul 2013
Granted: 24 Feb 2015
Term ends: Not estimatedThe source records don’t support an estimate.

Classification65 codes

A61K 35/28
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically…:…
A61F 2/141
Eye parts, e.g. lenses or corneal implants; Artificial eyes: artificial eyes
A61F 9/08
Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind;…:…
A61K 35/30
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically…:…

Family

Application61/565,358Us provisional application · filed 30 Nov 2011
US 2013/0183272 A1Pre-grant publication · published 18 Jul 2013
US 8,962,321 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results